Thermo Fisher Scientific Inc. (TMO) stock
Close on Nov 11, 2026Market cap $265.92BP/E 37.9Yield 0.24%
Thermo Fisher Scientific Inc. grew revenue 8.3% to $47.35B over the twelve months to Sep 26, 2026. Operating income rose 12.8% to $8.47B, moving the operating margin from 17.2% to 17.9%. Free cash flow was $7.60B, up 24.3% from a year earlier. At the latest close the market valued the company at $265.92B, 37.9 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 26, 2026
Valuation
- Market cap
- $265.92B
- P/E ratio
- 37.9
- Price to sales
- 5.62
- Price to book
- 4.86
- Dividend yield
- 0.24%
- Free cash flow yield
- 2.86%
Fundamentals
- Revenue
- $47.35B
- Net income
- $7.07B
- EPS, diluted
- $18.95
- Free cash flow
- $7.60B
- Book value per share
- $147.60
- Diluted shares
- 371M
Trading
- Next earnings
- Jan 28, 2027 (estimated, before the open)
- Previous close
- $718.20
- Open
- $719.69
- Day's range
- $716.47 – $727.56
- Volume
- 1,819,083
- Average volume (20 days)
- 2,373,271
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.82
- 52-week range
- $435.27 – $727.56
- RSI (14 days)
- 60.1
- Volatility (1 year)
- 30.0%
- Relative volume
- 0.85×
- WACC
- 8.4%
On 1 of our idea list: Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | TMO | S&P 500 | Difference | TMO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.1% | -2.4% | +11.5 pts | ||
| 3 months | +18.7% | -1.2% | +19.9 pts | ||
| Year to date | +24.2% | +12.3% | +11.9 pts | ||
| 1 year | +22.8% | +12.4% | +10.4 pts | ||
| 3 years | +61.6% | +78.8% | −17.2 pts | +17.4% | +21.4% |
| 5 years | +15.3% | +75.2% | −59.9 pts | +2.9% | +11.9% |
| 10 years | +388.1% | +311.1% | +77.0 pts | +17.2% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Thermo Fisher Scientific filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- News
About Thermo Fisher Scientific
Measuring & Controlling Devices, NEC
Thermo Fisher Scientific Inc. provides analytical instruments, laboratory equipment, consumables, reagents, and diagnostic test systems, alongside outsourced contract development and manufacturing services. The company reports its operations across four primary business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Key product offerings span biosciences, genetic analysis tools, chromatography and mass spectrometry systems, electron microscopes, clinical diagnostics, and comprehensive laboratory supplies. Thermo Fisher sells these offerings to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, research institutions, government agencies, and industrial and environmental testing facilities.
Company profile, executives and historyThermo Fisher Scientific stock: common questions
What is Thermo Fisher Scientific's stock price?
TMO closed at $717.71 on Nov 11, 2026, down 0.07% on the day. Over the past 52 weeks it traded between $435.27 and $727.56.
What is Thermo Fisher Scientific's market cap?
Thermo Fisher Scientific was worth $265.92B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is TMO's P/E ratio?
TMO trades at 37.9 times earnings, based on diluted earnings per share of $18.95 over the twelve months to Sep 26, 2026.
How much revenue does Thermo Fisher Scientific make?
Thermo Fisher Scientific reported revenue of $47.35B for the twelve months to Sep 26, 2026, up 8.3% from a year earlier.
Does Thermo Fisher Scientific pay a dividend?
Yes. Thermo Fisher Scientific paid $1.72 per share over the last twelve months, a yield of 0.24% at the latest price, and has raised its annual dividend 8 years in a row.
When does Thermo Fisher Scientific report earnings next?
Thermo Fisher Scientific is expected to report Q4 FY2026 results on Jan 28, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has TMO stock performed over the past year?
Including dividends, TMO returned +22.8% over the past year, against +12.4% for the S&P 500.
How many TMO shares are sold short?
5M shares were sold short at the latest FINRA report, 1.29% of the float, or 2.0 days of average trading volume.
Who are Thermo Fisher Scientific's competitors?
Companies most similar to Thermo Fisher Scientific by business, industry and size include DHR, A, AVTR, WAT, MTD.
See a number that looks wrong?